Home›Companies›Biotech & Pharma›NewLimit

NewLimit, Inc.

Updated Oct 27, 2026·Latest SEC filing May 15, 2025·Suggest an edit

About NewLimit

NewLimit is a private company based in South San Francisco, California, incorporated in 2021 in Delaware. It has reported $202,045,264 raised in two offerings on Form D since May 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 2, 2025May 15, 2025$129,799,764of $129.9M target38$3.4MEquityRule 506(b)Form D ↗
May 8, 2023May 17, 2023amended Jan 7, 2025$72,245,500fully sold21$3.4MEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$202,045,264

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on NewLimit's Form D filed May 15, 2025.

BA
ZD
Zavain Dar
Director
JK
Jacob Kimmel
President and director
BB
Blake Byers
Director

Earlier filings also listed Michael Polansky (president, last listed Jan 2025).

Sources

  1. SECNewLimit, Inc. Form D, filed May 17, 2023
  2. SECNewLimit, Inc. filing history